There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Fenofibrate (FF) is commonly used clinically as a lipid-lowering drug, but whether
it participates in endoplasmic reticulum (ER) stress and decreases inflammation in
skeletal muscle is still unknown. The aim of this study is to determine whether FF
treatment reduces insulin resistance (IR) by alleviating ER stress and downstream
inflammation in skeletal muscle tissues and cells.